News

However, Argus lowered the stock’s price target to $150 from $175 while keeping a Buy rating on April 17. The firm believes that the fresh US licensing requirements for AI chip exports ...
Illumina Inc. (NASDAQ: ILMN) and Tempus AI, Inc. (NASDAQ ... 2025 following the close of market on Thursday, May 8, 2025. Argus lowered the firm’s price target on Illumina (ILMN) to $100 ...
The technology is genuinely useful for scientific discovery, but its applications are less dramatic than you might think.
Researchers have discovered that a gene previously seen as a biomarker for Alzheimer’s disease, PHGDH, actually plays a ...
Tech expert Kurt “CyberGuy" Knutsson says a new autonomous AI is a game changer that also raises privacy risks. Is your data ...
A new study found that a gene recently recognized as a biomarker for Alzheimer's disease is actually a cause of it, due to its previously unknown secondary function that triggers a pathway that ...
Pressure to make cell and gene therapies more affordable will force the industry to overcome its reticence and embrace closed production systems, automation, and artificial intelligence (AI).
Eugene "Gene" Roegiers, age 90, of Eagle, ID, formerly of Jasper, MN, passed away on Monday, November 25, 2024. Memorial Service will be Saturday, April 26, 2025, at 10:30 AM at the Hartquist ...
Tempus AI has signed a three-way deal with AstraZeneca and Pathos AI to construct a data-based oncology model that could ...
The collaboration may also extend to future gene therapy programs, including those for Metabolic Dysfunction-Associated Steatohepatitis (MASH). Heureka’s AI platform aims to expedite the drug ...
The majority of AI firms operating in the UK are focused on creating generic AI solutions and not purposeful tools which solve a specific problem, a think tank has said. The Institute for Public ...
Claude, the high-powered AI assistant from start-up Anthropic, can now be linked with Google’s Gmail and Calendar to help with organisation tasks. Anthropic said the new link-up would be made ...